Clostridium Difficile Infection
📧 Sign up to get email alerts when something new happens for Clostridium Difficile Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Study of Metronidazole Delayed-Release Capsules in Comparison With Immediate-Release Tablets (Flagyl) for Safety and Pharmacokinetics [Phase 1]
A Phase 1 study comparing metronidazole delayed-release capsules with immediate-release Flagyl tablets to assess safety and pharmacokinetics…
-
CLINICAL_TRIALS trial_result · 2024-02-29Clinical Trial Update: Treatment of CDI and Recurrence With Fecal Microbiota Transplant Using Promicrobioma [Phase 3]
Phase 3 clinical trial update on fecal microbiota transplant with Promicrobioma for treatment and recurrence of Clostridium difficile infect…
-
CLINICAL_TRIALS trial_result · 2023-12-26Clinical Trial Update: Effect of Acid Suppression Medication on Pediatric Microbiome [NA]
A terminated pediatric trial investigated the effect of acid suppression medication on the microbiome in the context of Clostridium difficil…
-
CLINICAL_TRIALS trial_result · 2023-10-30Clinical Trial Update: Penn Microbiome Therapy (PMT) for Severe-Clostridium Difficile Infection (CDI) [Phase 2]
Phase 2 trial update for Penn Microbiome Therapy (PMT) in severe Clostridioides difficile infection, with termination and posted results.
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH) [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating microbiota transfer or placebo after antimicrobial therapy for recurrent Clostridium difficile infecti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection [Phase 2]
Phase 2 trial of VE303 for prevention of recurrent Clostridioides difficile infection has completed; results were posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-07Clinical Trial Update: Bezlotoxumab (MK-6072) Versus Placebo in Children With Clostridium Difficile Infection (CDI) (MK-6072-001) [Phase 3]
Phase 3 trial evaluating bezlotoxumab vs placebo in children with Clostridium difficile infection has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection [Phase 3]
Phase 3 trial update for SER-109 versus placebo in adults with recurrent Clostridium difficile infection (ECOSPOR III) completed with posted…
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Oral Vancomycin for Secondary Prophylaxis of Clostridium Difficile Infection (CDI) [Phase 4]
Phase 4 clinical trial update on oral vancomycin for secondary prophylaxis of recurrent Clostridium difficile infection has been terminated.
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Efficacy of 30-day Duration of Fidaxomicin for Recurrent C. Difficile Infection [Phase 3]
Phase 3 trial evaluating 30-day fidaxomicin duration for recurrent Clostridium difficile infection; study terminated with posted results in …
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI [Phase 2]
Phase 2 trial comparing fecal microbiota transplant to antimicrobials for initial treatment of recurrent Clostridium difficile infection; st…
-
CLINICAL_TRIALS trial_result · 2023-02-13Clinical Trial Update: Clostridium Difficile Vaccine Efficacy Trial [Phase 3]
Phase 3 trial results for a Clostridium difficile vaccine have been completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2022-12-16Clinical Trial Update: Treatment of Mild-moderate Clostridium Difficile Infection (CDI) [Phase 2]
Phase 2 clinical trial update for treatment of mild-to-moderate Clostridium difficile infection (CDI).
-
CLINICAL_TRIALS trial_result · 2022-12-13Clinical Trial Update: Fecal Microbiota Transplant (FMT) Plus Fidaxomicin for Severe or Fulminant Clostridium Difficile Infection [Phase 2]
Phase 2 trial of fecal microbiota transplant plus fidaxomicin for severe or fulminant Clostridium difficile infection has been terminated wi…
-
CLINICAL_TRIALS trial_result · 2022-11-30Clinical Trial Update: PROCLAIM -- Misoprostol in the Prevention of Recurrent CDI Prevent Recurrence of Clostridium Difficile Infection With Misoprostol [Phase 2]
Phase 2 trial evaluating misoprostol for prevention of recurrent Clostridium difficile infection was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-11-09Clinical Trial Update: Bezlotoxumab as Secondary Prophylaxis for C. Difficile in High-risk Hospitalized Patients Exposed to Antibiotics. [Phase 4]
Phase 4 trial update on bezlotoxumab as secondary prophylaxis for Clostridium difficile in high-risk hospitalized patients exposed to antibi…
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection [Phase 2]
Phase 2 exploratory study assessing safety, efficacy, and pharmacokinetics of intravenous DNV3837 in adults with Clostridium difficile infec…
-
CLINICAL_TRIALS trial_result · 2022-08-30Clinical Trial Update: Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection [Phase 2]
Phase 2 open-label extension trial update for CP101 (Oral Full-Spectrum Microbiota) in recurrent Clostridium difficile infection; results we…
-
CLINICAL_TRIALS trial_result · 2022-07-22Clinical Trial Update: Study of Bio-K+® in the Reduction of the Risk of Clostridium Difficile Infection and Antibiotic Associated Diarrhea [Phase 4]
Phase 4 trial investigating Bio-K+® for reducing risk of Clostridium difficile infection and antibiotic-associated diarrhea; study terminate…
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection [Phase 2]
Phase 2 clinical trial evaluating alanyl-glutamine supplementation added to standard treatment for Clostridium difficile infection; study te…
-
CLINICAL_TRIALS trial_result · 2022-05-26Clinical Trial Update: Bezlotoxumab (BEZLO) In Addition To Standard Of Care (SOC) Vancomycin For The Treatment of Multi-Recurrent Clostridium Difficile Infection [Phase 4]
Phase 4 trial evaluating bezlotoxumab in addition to standard vancomycin for multi-recurrent Clostridium difficile infection has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-19Clinical Trial Update: Prevention of Clostridium Difficile-associated Diarrhea by Daily Intake of Kefir [Phase 2]
Phase 2 trial assessing daily kefir intake to prevent Clostridium difficile-associated diarrhea; study terminated with results posted in 202…
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: Safety and Efficacy of FMT in Individuals With One or More Recurrences of Clostridium Difficile Associated Disease (CDAD) [Phase 1, Phase 2]
Phase 1/2 trial update on safety and efficacy of fecal microbiota transplantation (FMT) for individuals with recurrent Clostridium difficile…
-
CLINICAL_TRIALS withdrawal · 2022-04-29Clinical Trial Update: Fecal Microbiota Transplantation for Primary Clostridium Difficile Diarrhea [Phase 3]
A Phase 3 clinical trial investigating fecal microbiota transplantation for primary Clostridium difficile diarrhea was withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-03-25Clinical Trial Update: A Comparison of Fidaxomicin and Vancomycin in Patients With CDI Receiving Antibiotics for Concurrent Infections [Phase 4]
Phase 4 clinical trial comparing fidaxomicin to vancomycin in patients with Clostridium difficile infection who are receiving antibiotics fo…